Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Monitoring warfarin therapy in patients with lupus anticoagulants.

Moll S, Ortel TL.

Ann Intern Med. 1997 Aug 1;127(3):177-85.

PMID:
9245222
2.

Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?

Balaban M, Stanrić V, Rincić G, Ledinsky M, Grbac L, Stancić N, Tomasić H.

Acta Clin Croat. 2010 Dec;49(4):469-77. Review.

PMID:
21830460
3.

Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.

Crowl A, Schullo-Feulner A, Moon JY.

Ann Pharmacother. 2014 Nov;48(11):1479-83. doi: 10.1177/1060028014546361. Epub 2014 Aug 7. Review.

PMID:
25104566
4.

Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.

Spinler SA, Nutescu EA, Smythe MA, Wittkowsky AK.

Ann Pharmacother. 2005 Jun;39(6):1049-55. Epub 2005 Apr 26. Review.

PMID:
15855245
5.

Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Palareti G, Legnani C.

Clin Pharmacokinet. 1996 Apr;30(4):300-13. Review.

PMID:
8983860
6.

International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.

Oertel LB.

Nurse Pract. 1995 Sep;20(9):15-6, 21-2. Review.

PMID:
7501312
7.

Management of oral anticoagulant treatment in patients with venous thromboembolism.

Pengo V.

Semin Thromb Hemost. 2006 Nov;32(8):781-6. Review.

PMID:
17171590
8.

Quality measures and benchmarking for warfarin therapy.

Witt DM.

J Thromb Thrombolysis. 2011 Apr;31(3):242-8. doi: 10.1007/s11239-011-0570-0. Review.

PMID:
21327505
9.

[Prothrombin time and its standardization].

Kagawa K.

Rinsho Byori. 2002 Aug;50(8):779-85. Review. Japanese.

PMID:
12373814
10.

Reappraisal of thromboplastin.

Ziegler FD, Rich SA, Fasco MJ, Russell C, Kelly JH.

Ann Clin Lab Sci. 1981 May-Jun;11(3):202-10. Review.

PMID:
7018366
11.

[Current biological surveillance of oral anticoagulant treatment].

Helft G, Vacheron A, Samama MM.

Arch Mal Coeur Vaiss. 1995 Jan;88(1):85-9. Review. French.

PMID:
7646254
13.

Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine.

Traverso CI, Arcelus JI, Caprini JA.

Semin Thromb Hemost. 1995;21 Suppl 4:59-62. Review. No abstract available.

PMID:
8747690
14.

Optimal intensity and monitoring warfarin.

Hirsh J.

Am J Cardiol. 1995 Feb 23;75(6):39B-42B. Review.

PMID:
7863972
15.

Frequency of monitoring, non-adherence, and other topics dear to an anticoagulation clinic provider.

Clark NP.

J Thromb Thrombolysis. 2013 Apr;35(3):320-4. doi: 10.1007/s11239-013-0887-y. Review.

PMID:
23494486
16.

The INR: a perspective.

Smith RE.

Semin Thromb Hemost. 1997;23(6):547-9. Review.

PMID:
9469628
17.

Home monitoring of anticoagulation.

Hambleton J.

J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):39-42. Review.

PMID:
14760210
18.

[Role of laboratory monitoring in oral anticoagulant therapy].

D'Angelo G, Calvano D, Giardini C.

Minerva Med. 1993 Jun;84(6):313-22. Review. Italian.

PMID:
8336839
19.

How to monitor the dosage of warfarin.

Bussey HI.

Heart Dis Stroke. 1993 Sep-Oct;2(5):388-92. Review.

PMID:
8137040
20.

Laboratory monitoring of oral anticoagulant therapy.

Poller L, Samama M.

Clin Lab Med. 1994 Dec;14(4):813-23. Review.

PMID:
7874873
Items per page

Supplemental Content

Write to the Help Desk